Accendra Health, Inc.

Total Valuation

Accendra Health, Inc. carries a market capitalization of 240.47M, placing it among publicly traded companies globally. Its enterprise value stands at 2.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Accendra Health, Inc. currently has 76.58M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.06, and the price-to-book ratio stands at -0.19.

Enterprise Valuation

On an enterprise value basis, Accendra Health, Inc. trades at an EV/EBITDA multiple of 4.77 and an EV/FCF ratio of 10.77. The EV/Sales ratio of 0.74 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.70 provides insight into valuation relative to core operating earnings.

Financial Position

Accendra Health, Inc. maintains a current ratio of 0.49, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -467.04, indicating conservative leverage, while an interest coverage ratio of 3.65 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Accendra Health, Inc.'s stock has declined approximately -60.15228% over the past 52 weeks. The 50-day moving average sits at 3.11, while the 200-day moving average is 3.00.

Income Statement

Over the trailing twelve months, Accendra Health, Inc. generated 2.72B in revenue and converted that into -1.08B in net income, yielding earnings per share of -1.37. EBITDA reached 421.03M, while operating income came in at 187.67M.

Balance Sheet

Accendra Health, Inc. holds 336.88M in cash and equivalents against 2.17B in total debt, resulting in a net debt position of 1.77B. Total book value stands at -933.05M, with working capital of -614.60M providing operational flexibility.

Cash Flow

Accendra Health, Inc. produced -116.80M in operating cash flow over the past twelve months. After subtracting -195.69M in capital expenditures, free cash flow totaled -312.49M - equivalent to -4.07 per share.

Margins

Accendra Health, Inc. operates with a gross margin of 45.95, reflecting its pricing power and cost economics. The operating margin of 6.91 and net profit margin of -39.84 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Accendra Health, Inc.'s most recent stock split took place on April 1, 2010 with a 2:3 split ratio.

Scores

Accendra Health, Inc. posts an Altman Z-Score of 1.03, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.